Public-registry site landscape for NCT04372706, a Solid Tumor, AML Adult study sponsored by Rubius Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04372706 (registry record) |
| Sponsor | Rubius Therapeutics |
| Condition(s) | Solid Tumor, AML Adult |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 11 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04372706 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →